WHO:无症状者新型冠状病毒感染者传染人是罕见的!不能过于恐惧!

2020-02-02 不详 网络

根据世卫组织(WHO)官方媒体报道,传言“存在无症状冠状病毒感染者具有传染性”, 引起了国际旅行和交往中对中国人/华人产生了“偏见”。WHO公布最新冠状病毒疫情全球分布图WHO医疗专家在其官方媒体上声明:“无症状具有传染可能性很罕见(very rare)。” 此次新型冠状病毒和其他冠状病毒传播方式一样,无症状"携带者"罕见具有传染性。但是,WHO官员说“不完全排除患者出现明显症状前的传染

根据世卫组织(WHO)官方媒体报道,传言存在无症状冠状病毒感染者具有传染性”, 引起了国际旅行和交往中对中国人/华人产生了“偏见”。


WHO公布最新冠状病毒疫情全球分布图

WHO医疗专家在其官方媒体上声明:“无症状具有传染可能性很罕见(very rare)。” 此次新型冠状病毒和其他冠状病毒传播方式一样,无症状"携带者"罕见具有传染性。

但是,WHO官员说“不完全排除患者出现明显症状前的传染性。” 在SARS和MERS病例中也是如此,即绝大多数情形下是患者出现了病毒感染症状后才具有传染性。WHO专家希望澄清“无症状感染的传播说法,并且不是此次冠状病毒传播的主要"驱动力"。

上述结论是根据目前冠状病毒疫情的患者数据分析和已知冠状病毒感染机理得出的结论。WHO总干事强调:“这是事实的时刻,不是恐惧的时刻;这是科学的时刻,不是谣言的时刻;这是团结而不是污名的时刻。WHO需要共同努力战胜疫情。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636170, encodeId=3baf16361e08b, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Fri Apr 24 23:26:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840195, encodeId=5d471840195a4, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Tue Mar 10 12:26:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378903, encodeId=afbe3e890397, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 04 21:05:08 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467514, encodeId=366b146e514f1, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485059, encodeId=0f1514850597a, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1636170, encodeId=3baf16361e08b, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Fri Apr 24 23:26:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840195, encodeId=5d471840195a4, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Tue Mar 10 12:26:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378903, encodeId=afbe3e890397, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 04 21:05:08 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467514, encodeId=366b146e514f1, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485059, encodeId=0f1514850597a, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1636170, encodeId=3baf16361e08b, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Fri Apr 24 23:26:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840195, encodeId=5d471840195a4, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Tue Mar 10 12:26:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378903, encodeId=afbe3e890397, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 04 21:05:08 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467514, encodeId=366b146e514f1, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485059, encodeId=0f1514850597a, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
    2020-02-04 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1636170, encodeId=3baf16361e08b, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Fri Apr 24 23:26:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840195, encodeId=5d471840195a4, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Tue Mar 10 12:26:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378903, encodeId=afbe3e890397, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 04 21:05:08 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467514, encodeId=366b146e514f1, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485059, encodeId=0f1514850597a, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]
    2020-02-04 syscxl
  5. [GetPortalCommentsPageByObjectIdResponse(id=1636170, encodeId=3baf16361e08b, content=<a href='/topic/show?id=26eb3092232' target=_blank style='color:#2F92EE;'>#冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30922, encryptionId=26eb3092232, topicName=冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53a422597656, createdName=zjshifan_98647313, createdTime=Fri Apr 24 23:26:00 CST 2020, time=2020-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840195, encodeId=5d471840195a4, content=<a href='/topic/show?id=5e4158186f7' target=_blank style='color:#2F92EE;'>#新型冠状病毒感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58186, encryptionId=5e4158186f7, topicName=新型冠状病毒感染)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=shuangle, createdTime=Tue Mar 10 12:26:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=378903, encodeId=afbe3e890397, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Feb 04 21:05:08 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1467514, encodeId=366b146e514f1, content=<a href='/topic/show?id=ef32e9539e8' target=_blank style='color:#2F92EE;'>#罕见#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79539, encryptionId=ef32e9539e8, topicName=罕见)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=29f36868190, createdName=syscxl, createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485059, encodeId=0f1514850597a, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Feb 04 09:26:00 CST 2020, time=2020-02-04, status=1, ipAttribution=)]

相关资讯

胃病胃癌为什么会“传染”?我国幽门螺旋杆菌感染率已达59%

根据今年国际胃癌大会的报告,我国每年新增胃癌病例68万例,占全球发病总数的一半左右。 其中,最小的发病人群已低至25岁,40岁之后的胃癌发病率将增加1倍,其中男性发病率增长尤为显着。

极其罕见!葡萄牙父亲意外将艾滋病毒传染给儿子

据英国《每日邮报》9月27日报道,葡萄牙一名男孩出生后几天感染艾滋病病毒,原因竟是男孩父亲皮肤水孢破裂,液体从中流出,男孩接触后传染所

Science:对食物的选择和接受也会传染——社交改变“口味”

我们如何选择食物?瑞士日内瓦大学(UNIGE)的神经科学家通过研究啮齿动物食物选择的神经生物学机制,发现了伴侣对饮食习惯的重要且持久的影响。

What?水痘患者需要戴外科口罩?

故事发生在2018年2月20日的上午,爱岗敬业的小编去皮肤科门诊督导院感工作时,正遇到一位20多岁的小伙子来皮肤科门诊看医生。

Hum reprod update:寨卡病毒感染对生殖有怎样的影响?

背景:寨卡病毒(ZIKV)是黄病毒属、Flaviviridae病毒家族的一种节肢型病毒。目前,ZIKV处于大流行,是世界公共卫生紧急情况的焦点。虽然1947年ZIKV就被分离出来,但它的病理机制仍然不甚清楚,而且直到现在,也才有几篇关于它的文章。ZIKV的传播途径及其对生育和妊娠的影响最近才开始公开。目的:本文对ZIKV感染及其病理过程的相关进展进行总结,重度是它对两性生殖道的影响,包括性传播和妊

PANS:颠覆认知:流感可能仅通过呼吸传播,并不需要咳嗽和打喷嚏

马里兰大学牵头的一项最新的研究显示,流感病毒(流感)的传播比以往认为的还要容易。人们通常认为,接触受感染者咳嗽或喷嚏的液滴,或着接触受病毒污染的表面会感染流感。但是,关于流感传播的这项最新研究表明,我们可能只通过呼吸就把流感传染给其他人。